The immunohistochemical staining and western blotting results indicated that CD133 was obviously increased in lung cancer tissues compared to non-lung cancer tissues which were consistent with Olig2 expression (Fig. 3a–d). This evidence concerns the gene OLIG2 and lung cancer.